STAT Plus: After Eli Lilly granted one man special access to obesity drug, doctors struggle to get answers STAT 11h Eli Lilly Obesity Pharma
AIDS 2026: HIV cure strategies, with or without latency reversal BioWorld 13h AIDS HIV Pharma Article paywall
Decoy therapeutics expands Intellectual Property portfolio covering Designable Multi-Antivirals and the imp³act™ platform PR Newswire (Press Release) 16h Biotechnology
Polpharma Biologics gains FDA and EMA review acceptances PharmaTimes 13h FDA Inflammatory Bowel Disease
FTSE 100 movers: AstraZeneca tumbles on merger report; housebuilders rally ShareCast 14h FTSE 100 AstraZeneca Mergers and Acquisitions Article paywall
Ezplaz freeze-dried plasma receives FDA approval for transfusion Renal and Urology News 13h FDA Science
AstraZeneca and Bristol-Myers Squibb: Megamerger reports leave us scratching our heads MorningStar.com 13h Bristol Myers Squibb AstraZeneca
